1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Yield10 Bioscience Inc (YTEN) Files 10-K for the Fiscal Year Ended on December 31, 2019

March 25, 2020 | About:

Yield10 Bioscience Inc (NASDAQ:YTEN)(30-Year Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2019. Yield10 Bioscience Inc, formerly known as Metabolix Inc is an agricultural bioscience company. It is engaged in the development of disruptive technologies to produce the improvements in crop yield for food and feed crops to enhance food security. Yield10 Bioscience Inc has a market cap of $6.547 million; its shares were traded at around $3.81 with and P/S ratio of 1.55. GuruFocus has detected 3 severe warning signs with Yield10 Bioscience Inc. .

For the last quarter Yield10 Bioscience Inc reported a revenue of $0.14 million, compared with the revenue of $0.14 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $0.81 million, an increase of 45% from last year. For the complete 30-year financial data, please go here.. For the last five years Yield10 Bioscience Inc had an average revenue decline of 22.9% a year.

The reported loss per diluted share was $35.5 for the year, compared with the loss per share of $380 in the previous year. The Yield10 Bioscience Inc had an operating margin of -1222.08%, compared with the operating margin of -1667.99% a year before. The 10-year historical median operating margin of Yield10 Bioscience Inc is -970.78%. The profitability rank of the company is 2 (out of 10).

At the end of the fiscal year, Yield10 Bioscience Inc has the cash and cash equivalents of $5.42 million, compared with $3.02 million in the previous year. The long term debt was $3.62 million, compared with $0.94 million in the previous year. Yield10 Bioscience Inc has a financial strength rank of 2 (out of 10).

At the current stock price of $3.81, Yield10 Bioscience Inc is traded at 87% discount to its historical median P/S valuation band of $29.23. The P/S ratio of the stock is 1.55, while the historical median P/S ratio is 14.58. The stock lost 92.29% during the past 12 months.

For the complete 20-year historical financial data of YTEN, click here.


Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)